header logo image

Genetic and COVID-19 Testing Companies Set To Be Regulated in California – JD Supra

September 6th, 2020 12:00 pm

In the last days of the most recent legislative session, the California State Legislature was busy passing several privacy bills set to impact businesses. The most recent, the Genetic Information Privacy Act, would require companies that sell and market consumer-focused genetic testing products directly to consumers (including COVID-19 testing companies) to comply with certain privacy requirements.

If signed by Governor Newsom, the Genetic Information Privacy Act will require the following:

The responsibilities set upon businesses and the rights afforded to consumers reflect a pattern emerging in consumer privacy legislation, most notably, the California Consumer Privacy Act, which went into effect on January 1, 2020, and into full enforcement on August 14, 2020.

The Act goes further to ensure that consumers genetic data will not be disclosed to health insurers, insurance providers, or employers who may make decisions regarding provision of coverage or employment to an individual consumer.

With the adaptation and growth of testing companies that have emerged in the wake of COVID-19, established businesses and startups alike must heed this new regulation.

View post:
Genetic and COVID-19 Testing Companies Set To Be Regulated in California - JD Supra

Related Post

Comments are closed.


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick